Toll Free: 1-888-928-9744
Published: Mar, 2015 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Aduro BioTech, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Aduro BioTech, Inc. - Product Pipeline Review - 2015', provides an overview of the Aduro BioTech, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Aduro BioTech, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Aduro BioTech, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Aduro BioTech, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Aduro BioTech, Inc.'s pipeline products Reasons to buy - Evaluate Aduro BioTech, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Aduro BioTech, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Aduro BioTech, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Aduro BioTech, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Aduro BioTech, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Aduro BioTech, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of table 4 List of Figures 4 Aduro BioTech, Inc. Snapshot 5 Aduro BioTech, Inc. Overview 5 Key Information 5 Key Facts 5 Aduro BioTech, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Aduro BioTech, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Out-Licensed Products 10 Out-Licensed Products/Combination Treatment Modalities 11 Aduro BioTech, Inc. - Pipeline Products Glance 12 Aduro BioTech, Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Aduro BioTech, Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Aduro BioTech, Inc. - Drug Profiles 15 Cell Therapy to Target GM-CSFR for Pancreatic Cancer 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 CRS-207 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 ADU-623 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Cell Therapy to Target GM-CSFR for Melanoma 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 ADU-214 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 ADUS-100 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 anthrax vaccine 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Small Molecules for Oncology 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 STINGVAX 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Vaccines for Oncology 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Aduro BioTech, Inc. - Pipeline Analysis 28 Aduro BioTech, Inc. - Pipeline Products by Target 28 Aduro BioTech, Inc. - Pipeline Products by Route of Administration 29 Aduro BioTech, Inc. - Pipeline Products by Molecule Type 30 Aduro BioTech, Inc. - Recent Pipeline Updates 31 Aduro BioTech, Inc. - Dormant Projects 35 Aduro BioTech, Inc. - Locations And Subsidiaries 36 Head Office 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38
List of Tables Aduro BioTech, Inc., Key Information 5 Aduro BioTech, Inc., Key Facts 5 Aduro BioTech, Inc. - Pipeline by Indication, 2015 7 Aduro BioTech, Inc. - Pipeline by Stage of Development, 2015 8 Aduro BioTech, Inc. - Monotherapy Products in Pipeline, 2015 9 Aduro BioTech, Inc. - Out-Licensed Products in Pipeline, 2015 10 Aduro BioTech, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11 Aduro BioTech, Inc. - Phase II, 2015 12 Aduro BioTech, Inc. - Phase I, 2015 13 Aduro BioTech, Inc. - Preclinical, 2015 14 Aduro BioTech, Inc. - Pipeline by Target, 2015 28 Aduro BioTech, Inc. - Pipeline by Route of Administration, 2015 29 Aduro BioTech, Inc. - Pipeline by Molecule Type, 2015 30 Aduro BioTech, Inc. - Recent Pipeline Updates, 2015 31 Aduro BioTech, Inc. - Dormant Developmental Projects,2015 35
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.